[HTML][HTML] Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders

S Rana, SD Burke, SA Karumanchi - American journal of obstetrics and …, 2022 - Elsevier
Preeclampsia is a devastating medical complication of pregnancy that can lead to significant
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …

Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome

H Stepan, M Hund, T Andraczek - Hypertension, 2020 - Am Heart Assoc
Placental dysfunction underlies a spectrum of perinatal pathologies, including preeclampsia
and fetal growth restriction. Angiogenesis-related factors, including sFlt-1 (soluble fms-like …

[PDF][PDF] ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction

CC Lees, T Stampalija, AA Baschat… - Ultrasound in Obstetrics …, 2020 - arts.units.it
The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) is a scientific
organization that encourages sound clinical practice, and high-quality teaching and …

The placental basis of fetal growth restriction

RL Zur, WT Parks, SR Hobson - Obstetrics and Gynecology …, 2020 - obgyn.theclinics.com
The past decade has seen a substantial advancement in our understanding of placental
diseases that are associated with fetal growth restriction (FGR). 1 This increased …

A maternal serum metabolite ratio predicts fetal growth restriction at term

U Sovio, N Goulding, N McBride, E Cook, F Gaccioli… - Nature medicine, 2020 - nature.com
Fetal growth restriction (FGR) is the major single cause of stillbirth and is also associated
with neonatal morbidity and mortality,, impaired health and educational achievement in …

Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor) ratio in Asian women with suspected …

X Bian, A Biswas, X Huang, KJ Lee, TKT Li… - …, 2019 - Am Heart Assoc
Current diagnostic criteria have limited clinical value for prediction of preeclampsia and fetal
adverse outcomes. The prediction of short-term outcome in pregnant women with suspected …

[HTML][HTML] Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia

S Verlohren, SP Brennecke, A Galindo… - Pregnancy …, 2022 - Elsevier
Preeclampsia is associated with significant morbidity and mortality for mother and baby.
Although around 30% of all pregnancies are evaluated for preeclampsia, diagnosis is …

The possible role of placental morphometry in the detection of fetal growth restriction

N Salavati, M Smies, W Ganzevoort, AK Charles… - Frontiers in …, 2019 - frontiersin.org
Fetal growth restriction (FGR) is often the result of placental insufficiency and is
characterized by insufficient transplacental transport of nutrients and oxygen. The main …

PlGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center

K McLaughlin, JW Snelgrove, MC Audette, A Syed… - …, 2021 - Am Heart Assoc
There is little evidence evaluating angiogenic growth factor testing in real-world obstetric
settings. This investigation evaluated maternal and perinatal pregnancy outcomes …

Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre …

J Henrichs, V Verfaille, P Jellema, L Viester, E Pajkrt… - bmj, 2019 - bmj.com
Objectives To investigate the effectiveness of routine ultrasonography in the third trimester in
reducing adverse perinatal outcomes in low risk pregnancies compared with usual care and …